...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Not adding up!
2
Nov 15, 2021 10:37AM
2
Nov 15, 2021 11:40AM
2
Nov 15, 2021 12:43PM

"2. You are expecting some jaw-dropping numbers over at Resverlogix with regards to the Covid-19 trial?"

"Different company.  How is this relevant?"

 

IMO its relevent because again IMO RVX is the "grandfather" of Zen Science. Zen seems more like an arm of this science/rvx or vice versa to me & too top it off their both ruled by the same CEO.

If something reflects/comes off well in one company it is a reflection of sorts of the other - how big a reflection, not sure but none the less i feel it is relevant to a point. 

3
Nov 15, 2021 01:46PM
2
Nov 15, 2021 02:05PM
3
Nov 15, 2021 02:21PM
1
Nov 15, 2021 04:05PM
3
Nov 15, 2021 09:09PM
1
Nov 16, 2021 09:53AM
3
Nov 16, 2021 12:02PM
4
Nov 16, 2021 12:18PM
6
Nov 16, 2021 03:37PM
Share
New Message
Please login to post a reply